Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter

Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility

Terumo Neuro’s Sofia Flow 88 Launched in EMEA Markets - Endovascular Today

June 2, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia Flow 88 neurovascular aspiration catheter in the Europe, Middle East, and Africa (EMEA) markets. According to Terumo Neuro, the Sofia 88 neurovascular aspiration catheter offers an 0.088-inch inner diameter and is designed to provide reliable trackability, procedural flexibility, and physician control. The company stated…

Terumo Neuro Announces EMEA Commercial Availability Of The SOFIA Flow 88 Neurovascular Aspiration Catheter - Medical Device News Magazine

The launch builds on the proven clinical performance and global legacy of the SOFIA™ Catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade. Terumo Neuro is showcasing its complete line of stroke solutions at LINNC Paris this week at Le Carrousel du Louvre, booth number 8.